Taking into consideration that polymorphic variations of the PON cluster gene directly affect PONs’ activity, concentration and the binding regulatory elements it is reasonable to believe that they may contribute to atherosclerosis–related diseases, such as coronary artery disease, stroke, peripheral artery disease, diabetes mellitus, dementia and renal disease. This evidence concerns the gene PON1 and kidney disorder.